oral tirzepatide clinical trials ‼️Obesity slots almost all filled! There are still some spots for those with diabetes available , Obesity trial alert 👀, This is a phase 3 clinical trial enrolling 800 adults, last about 89 Eli Lilly plans diabetes drug

STEP and SELECT Trial Data, What Researchers Are Working From The pivotal STEP 1 trial (Wilding et al., NEJM 2021, NCT03548935) enrolled 1,961 adults with obesity (no T2D) over 68 weeks at the 2.4mg/week dose

The research also showed that the chances of a major cardiovascular event were 18% lower in the semaglutide group, after tracking patients for more than three years.*1 However, other large studies have found that when people stop using semaglutide, weight often simply piles right back on

Also, a generic version of Saxenda reached pharmacies in August 2025, and its 14% cheaper than Zepbound

Die Dosierungsempfehlungen sind klar und leicht verstndlich